PMC7720342_01
Initial presentation with bilateral temporal tarsorrhaphies.
10.1177_2515841420971927-fig1.jpg
PMC7720342_01_10.1177_2515841420971927-fig1.jpg
fig1-2515841420971927
Lagophthalmos of 2 mm was noted in the right eye and 1 mm in the left eye (Figure 1).
Post-operative day 5, after removal of lateral lid lesions.
10.1177_2515841420971927-fig2.jpg
PMC7720342_01_10.1177_2515841420971927-fig2.jpg
fig2-2515841420971927
By postoperative day 5, lateral lid adhesions were noted and released at the slit lamp (Figure 2) after bolster removal.
Refusion of lateral tarsorrhaphies.
10.1177_2515841420971927-fig3.jpg
PMC7720342_01_10.1177_2515841420971927-fig3.jpg
fig3-2515841420971927
Unfortunately, re-fusion occurred again by postoperative month 2 (Figure 3).
Cyanoacrylate glue to secure amniotic membrane grafts.
10.1177_2515841420971927-fig4.jpg
PMC7720342_01_10.1177_2515841420971927-fig4.jpg
fig4-2515841420971927
Intraoperatively, AMGs were draped over the marginal surfaces to prevent re-fusion and bolsters were placed (Figures 4-6).
Foam bolsters with IV tubing between graft surfaces.
10.1177_2515841420971927-fig5.jpg
PMC7720342_01_10.1177_2515841420971927-fig5.jpg
fig5-2515841420971927
Intraoperatively, AMGs were draped over the marginal surfaces to prevent re-fusion and bolsters were placed (Figures 4-6).
Laying out amniotic membrane graft over external eyelid surfaces.
10.1177_2515841420971927-fig6.jpg
PMC7720342_01_10.1177_2515841420971927-fig6.jpg
fig6-2515841420971927
Intraoperatively, AMGs were draped over the marginal surfaces to prevent re-fusion and bolsters were placed (Figures 4-6).
Post-operative month 9.
10.1177_2515841420971927-fig7.jpg
PMC7720342_01_10.1177_2515841420971927-fig7.jpg
fig7-2515841420971927
At postoperative month 9, no re-fusion had occurred (Figure 7) and patient was happy with the cosmetic outcome.